HR 3092 · 119th Congress — Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2025

Summary

Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2025 This bill requires, as a condition for Medicare payment, specified electrodiagnostic services to be furnished by qualified facilities that comply with accreditation, training, and other quality control requirements, as established under the bill. Specifically, the bill requires nerve conduction studies and needle electromyography tests to be furnished by facilities that are accredited by an organization that is approved by the Centers for Medicare & Medicaid Services (CMS). The accrediting organization must certify that the facility meets certain standards, including having a quality control program and requiring those who administer needle electromyography tests to have at least three months of specialized training. The bill also establishes an advisory committee to support the CMS in developing appropriate facility standards.

This summary may describe an earlier version. Check the official record for current wording.

Latest action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sponsors

• Rep. Sessions, Pete [R-TX-17]

  Republican · Texas · House District 17 · Republican

Sources

• Official congressional record ↗